Check-Cap (NASDAQ:MBAI – Get Free Report) and Nanovibronix (NASDAQ:FEED – Get Free Report) are both small-cap manufacturing companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.
Risk and Volatility
Check-Cap has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500.
Profitability
This table compares Check-Cap and Nanovibronix’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Check-Cap | N/A | N/A | N/A |
| Nanovibronix | -275.12% | -24.78% | -19.24% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Check-Cap | 1 | 0 | 0 | 0 | 1.00 |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
Earnings and Valuation
This table compares Check-Cap and Nanovibronix”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Check-Cap | N/A | N/A | -$25.15 million | ($2.77) | -0.60 |
| Nanovibronix | $2.56 million | 1.17 | -$3.70 million | ($41.74) | -0.07 |
Nanovibronix has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 5.2% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Nanovibronix beats Check-Cap on 6 of the 10 factors compared between the two stocks.
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.
